ProShare Advisors’s CytRx Corp CYTR Stock Holding History

ProShare Advisors’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,084	Closed	-$6K	–	1582
2017 Q1	$6K	Sell	2,084 -513	-20%	-$1.3K	﹤0.01%	1557
2016 Q4	$6K	Buy	+2,597	New	+$7.63K	﹤0.01%	1740
2015 Q2	–	Sell	-1,796	Closed	-$36K	–	1922
2015 Q1	$36K	Sell	1,796 -172	-9%	-$3.2K	﹤0.01%	1890
2014 Q4	$32K	Sell	1,968 -1,695	-46%	-$26.4K	﹤0.01%	1948
2014 Q3	$56K	Sell	3,663 -828	-18%	-$16.4K	﹤0.01%	2250
2014 Q2	$113K	Buy	+4,491	New	+$102K	﹤0.01%	2330

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

ProShare Advisors's CYTR Position: Q2 2017 in Review

ProShare Advisors sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 2,084 shares — an estimated $6K sold.

ProShare Advisors first reported a position in CYTR in Q2 2014 and held it in 6 quarters. The position peaked at $113K in Q2 2014. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

ProShare Advisors reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
ProShare Advisors sold 2,084 CytRx Corp shares in Q2 2017, an estimated $6K.
ProShare Advisors first reported a position in CytRx Corp in Q2 2014 and held it in 6 quarters.
ProShare Advisors's CytRx Corp position peaked at $113K in Q2 2014.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on ProShare Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.